+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NOVARTIND NOVARTIND

Novartis India Share Price

 
New 52W High in past week

 

Novartis India live price: ₹1,570.30. It opened at ₹1,597 vs previous close ₹1,603; intraday high/low: ₹1,597/₹1,537. The 50 & 200 DMA stand at ₹1,377.50/₹1,100.80.

Novartis India Performance

  • Today's Low
  • ₹1,537
  • Today's High
  • ₹1,597
  • 52 Week Low
  • ₹750
  • 52 Week High
  • ₹1,722
  • Open Price₹1,597
  • Previous Close₹1,603
  • Volume27,769
  • 50 DMA₹1,377.50
  • 100 DMA₹1,234.40
  • 200 DMA₹1,100.80

Novartis India Chart

Investment Returns

  • Over 1 Month + 18.84%
  • Over 3 Month + 57.08%
  • Over 6 Month + 95.86%
  • Over 1 Year + 48.83%

Smart Investing Starts Here Start SIP with Novartis India for Steady Growth!

Invest Now

Novartis India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.6
  • PEG Ratio
  • -5.4
  • Market Cap Cr
  • 3,877
  • P/B Ratio
  • 4.7
  • Average True Range
  • 80.1
  • EPS
  • 37.7
  • Dividend Yield
  • 1.6
  • MACD Signal
  • 62
  • RSI
  • 60.71
  • MFI
  • 80.99

Latest Stock News Updates

Novartis India Ltd - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, issued to Novartis India Limited ("The Company") by the Registrar to an Issue & Share Transfer Agent ("RTA") of the company.

Novartis India Ltd - 500672 - Post-Offer advertisement

Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the Public Shareholders of Novartis India Ltd ("Target Company").

Novartis India Ltd - 500672 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Novartis India Limited ("The Company").

Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.

Novartis India Financials

Novartis India Technicals

EMA & SMA

Current Price
₹1,570.30
-33.1 (-2.06%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹1,495.70
  • 50 Day
  • ₹1,377.50
  • 100 Day
  • ₹1,234.40
  • 200 Day
  • ₹1,100.80

Resistance and Support

1568.3 Pivot Speed
  • R3 1,659.50
  • R2 1,628.40
  • R1 1,599.40
  • S1 1,539.20
  • S2 1,508.10
  • S3 1,479.10

Novartis India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-23 Quarterly Results
2026-05-12 Audited Results
2026-01-28 Quarterly Results
2025-10-28 Quarterly Results
2025-07-29 Quarterly Results
Date Purpose Remarks
2025-07-23 FINAL Rs.25.00 per share(500%)Final Dividend
View Novartis India Dividend History Arrow
Date Purpose Remarks
2000-11-06 Split Demerger of Agro Business Division

Novartis India Shareholding Pattern

70.68%
28.6%
0.53%
0.17%

Novartis India FAQs

Novartis India share price is ₹1,570 As on 17 July, 2026 | 23:12

The Market Cap of Novartis India is ₹3877.2 Cr As on 17 July, 2026 | 23:12

The P/E ratio of Novartis India is 41.6 As on 17 July, 2026 | 23:12

The PB ratio of Novartis India is 4.7 As on 17 July, 2026 | 23:12

The 52 week High & Low of Novartis India is ₹1722.2/₹750 respectively As on 17 July, 2026 | 23:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23